USFDA accepts AstraZeneca’s BLA for nirsevimab to prevent RSV lower respiratory tract disease Read more
Lupin launches novel fixed-dose triple drug combination Difizma DPI to treat inadequately controlled asthma Read more
Boosting stakeholder supply chain visibility and enhancing pharma logistics through internet Read more